Tech Company Financing Transactions
Chronix Biomedical Funding Round
On 5/19/2017, Chronix Biomedical raised $1.5 million in funding from private investors.
Transaction Overview
Company Name
Announced On
5/19/2017
Transaction Type
Venture Equity
Amount
$1,471,041
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 25 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5941 Optical Ct. 203e
San Jose, CA 95138
USA
San Jose, CA 95138
USA
Phone
Website
Email Address
Overview
Chronix Biomedical has created laboratory developed tests to minimize the number of unnecessary biopsies due to cancer screen false positives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ekkehard Schutz
Chief Financial Officer
John DiPietro
Chief Scientific Officer
Howard Urnovitz
Browse more venture capital transactions:
Prev: 5/19/2017: Riptide IO venture capital transaction
Next: 5/19/2017: Dor venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs